Rare Disease Advocates Lobby US Congress For FDA Center of Excellence

 
• By Derrick Gingery

Number one ask is for congressional pressure to centralize rare disease expertise at the agency, but advocates also are preparing legislation that would mandate the new center.

FDAEntrance_1200x675
Rare disease advocates also want increased funding for the FDA Office of Orphan Products Development's clinical trial and natural history grant programs. • Source: File photo

More from US FDA

More from Agency Leadership